Ranibizumab in retinopathy of prematurity – one‐year follow‐up of ophthalmic outcomes and two‐year follow‐up of neurodevelopmental outcomes from the CARE‐ROP study. - Stahl, Andreas; Bründer, Marie‐Christine; Lagrèze, Wolf A.; Molnár, Fanni E.; Barth, Teresa; Eter, Nicole; Guthoff, Rainer; Krohne, Tim U.; Pfeil, Johanna M.; Bühler, Anima; Daniel, Moritz; Felzmann, Susanne; et al. (Acta Ophthalmologica (1755375X), 2022)